ARTICLE | Company News
PregLem, Merck KGaA deal
August 16, 2010 7:00 AM UTC
Merck's Merck Serono S.A. unit granted PregLem exclusive, worldwide rights to develop and commercialize bentamapimod. Merck will receive an upfront payment and is eligible for milestones and royalti...